Coronavirus drug | Dr Reddy#39;s inks pact with Gilead Sciences to manufacture remdesivir

As per the non-exclusive licensing agreement, Gilead will grant Dr Reddy#39;s Laboratories the right to register and manufacture its investigational Coronavirus drug remdesivir in 127 countries.

from Moneycontrol Business News https://www.moneycontrol.com/news/business/coronavirus-drug-|-dr-reddy39s-inks-pactgilead-sciences-to-manufacture-remdesivir_13898761.html